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Abstract 
Background: Ebolaviruses have been known to cause deadly disease in humans for 
40 years and have recently been demonstrated in West Africa to be able to cause 
large outbreaks. Four Ebolavirus species cause severe disease associated with high 
mortality in humans. Reston viruses are the only Ebolaviruses that do not cause 
disease in humans. Conserved amino acid changes in the Reston virus protein VP24 
compared to VP24 of other Ebolaviruses have been suggested to alter VP24 binding 
to host cell karyopherins resulting in impaired inhibition of interferon signalling, which 
may explain the difference in human pathogenicity. Here we used protein structural 
analysis and molecular dynamics to further elucidate the interaction between VP24 
and KPNA5. 
Results: As a control experiment, we compared the interaction of wild-type and 
R137A-mutant (known to affect KPNA5 binding) Ebola virus VP24 with KPNA5. 
Results confirmed that the R137A mutation weakens direct VP24-KPNA5 binding and 
enables water molecules to penetrate at the interface.  Similarly, Reston virus VP24 
displayed a weaker interaction with KPNA5 than Ebola virus VP24, which is likely to 
reduce the ability of Reston virus VP24 to prevent host cell interferon signalling.  
Conclusion: Our results provide novel molecular detail on the interaction of Reston 
virus VP24 and Ebola virus VP24 with human KPNA5. The results indicate a weaker 
interaction of Reston virus VP24 with KPNA5 than Ebola virus VP24, which is probably 
associated with a decreased ability to interfere with the host cell interferon response. 
Hence, our study provides further evidence that VP24 is a key player in determining 
Ebolavirus pathogenicity. 
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Background 
The potential of Ebolaviruses to cause large outbreaks has been highlighted by the recent 
Ebola virus outbreak in West Africa [1] resulting in 28,657 confirmed cases and 11,325 deaths 
as of 8th May 2016 (www.who.int). To enable replication, viruses depend on mechanisms to 
antagonise the host cell interferon response. The Ebolavirus proteins that are known to be 
crucially involved in the suppression of interferon signalling are VP35 and VP24 [2-6]. VP35 
prevents interferon signalling by binding and masking double stranded viral RNA. VP24 
impairs the host interferon response by binding to the karyopherins D1 (KPNA1), D5 (KPNA5) 
and D6 (KPNA6) and the transcription factor STAT1 [3-5]. Karyopherins would normally bind 
STAT1 and transport it to the nucleus, a key step during interferon signalling. VP24 prevents 
this transport and the subsequent accumulation of STAT1 in the nucleus [2-6]. 
 
Of the five known Ebolavirus species, only Reston viruses are not pathogenic in humans [7]. 
A recent study identified genetic variants, that result in amino acid substitutions between the 
four human-pathogenic Ebolavirus species and Reston viruses that may explain the 
discrepancy in human pathogenicity [8]. Certain amino acid changes (T131S, M136L, Q139R 
± Ebola virus residue listed first and Reston virus residue second) in the VP24-karyopherin 
interface (Figure 1) were proposed to reduce the affinity of Reston virus VP24 to human 
karyopherins resulting in a (compared to other Ebolavirus VP24 proteins) reduced ability to 
inhibit interferon signalling. 
 
In this study, we compared the interaction of Ebola virus and Reston virus VP24 with human 
KPNA5 using protein structural analysis and molecular dynamics simulations.  
 
Results 
Analysis of the effect of Ebola VP24 mutations on interaction with KPNA5.  
The crystal structure of the Ebola virus VP24 complex with KPNA5 is available [3] as well as 
co-immunoprecipitation studies that have investigated the effect of mutations on the ability of 
Ebola virus VP24 to bind KPNA5. The experimental data has shown that the Ebola virus VP24 
mutations R137A and the combination of R137A,T138A,Q139A strongly reduce VP24-KPNA5 
binding. Combined F134A,M136A mutations resulted in an intermediate level of VP24-KPNA5 
binding. Other single point mutations (including Q139A that we used as a control) had limited 
effect on VP24-KPNA5 binding [3]. 
 
Initially, we used mCSM [9] and FoldX [10] to predict the effect of the investigated mutations 
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on the stability of the Ebola virus VP24-KPNA5 complex (mCSM, FoldX) and the affinity of the 
proteins (mCSM) (see methods). mCSM predicted that both point mutations, R137A and 
Q139A, reduce the binding affinity and the stability of the complex, with the R137A mutation, 
however, having a greater effect (predicted (''G -1.07 kcal/mol change in complex affinity) 
than Q139A (Table 1). Note that for mCSM negative ''G values indicate that the mutation is 
predicted to destabilise the interaction, while positive values stabilise the interaction. The FoldX 
predictions agree with mCSM for both point mutations. Additionally, FoldX was able to 
consider combinations of mutations simultaneously and predicted that both sets of mutations 
(F134A,M136A, and R137A,T138A,Q139A) reduce stability of the complex with a large 
reduction of more than -7 kcal/ml for the F134A, M136A combination (Table 1). These 
predictions are generally in agreement with the experimental observations that R137A and 
the two sets of multiple mutation reduce binding of Ebola VP24 with KPNA5 and that Q139A 
results in less pronounced effects [3]. 
 
Next, molecular dynamics simulations (MD) for both the wild type Ebola virus VP24 and 
mutated forms were performed. MD simulations were obtained for the wild type complexes 
and for the mutated Ebola virus VP24 forms: 1)R137A, 2)Q139A, 3)F134A,M136A and  
4)R137A,T138A,Q139A. First the amount of positional fluctuation during the simulation for 
each residue in VP24 and KPNA5 was considered by calculating the Root Mean Squared 
Fluctuation (RMSF; Figure 2). This analysis showed that for all four mutation sets, a greater 
fluctuation variability is observed in KPNA5. Additionally, for all mutations there is increased 
fluctuation in VP24 in the interface and in the vicinity of the mutated residues (Figure 2). This 
fluctuation is much greater for the three sets of mutations that have an effect on the interaction 
between VP24 and KPNA5 and smallest for Q139A, which affects binding to a lesser extent 
(Figure 2).  
 
Investigating the effects of VP24 R137A mutation on interaction with KPNA5 
According to the experimental data from Xu et al [3] the single point mutation R137A is the 
only point mutation that largely removes binding of VP24 to KPNA5. Thus, we used this 
mutation to validate our system and to obtain additional molecular information on the 
interaction between the two proteins. The RMSF calculations (Figure 2) indicated the greatest 
movement compared to the wild type VP24 centred around residue 115 and also from 
residues 135 to 150.  
To consider how this mutation affects the interaction between VP24 and KPNA5, we analysed 
the correlation of conformational changes within the complexes and investigated the solvation 
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properties at the interface. The solvation properties for the wild type and R137A-mutated VP24 
complexes with human KPNA5 were calculated by estimating the water density on a grid of 
points constructed around the residues at the interface (see methods). This analysis gave a 
detailed description of how the solvation influences the binding of VP24 and KPNA5 (Figure 
4).  
 
By considering how frequently each grid point (represented as spheres in Figure 4) was visited 
by water molecules, we were able to identify solvation sites at the interface in a continuum 
UDQJHIURP³ORZGHQVLW\´JULGSRLQWVVKRUWWHPSRUDOSHUPDQHQFH>SV@ of water molecules, red 
VSKHUHV LQ)LJXUH WR³KLJKGHQVLW\´JULGSRLQWV ORQJ WHPSRUDOSHUPDQHQFH >QV@RIZDWHU
molecules, blue spheres in Figure 4).  
 
In the wild type Ebola virus complex, high density grid points were found close to the residues 
N185, H186, E203, P204 and D205 (Figure 4). This means that at the interface there are 
solvation sites where water molecules are trapped and contribute to stabilise the complex. In 
contrast, the mutant R137A VP24-KPNA5 complex at the interface is characterised only by 
low density grids points, meaning that water molecules do not strongly localise stably at this 
spot and consequently they are not likely to contribute to the stabilisation of the complex. The 
mutation induces a long-range destabilisation of the complex creating a cleft at the interface 
where water molecules can freely enter and exit (Figure 4B). This is an indication that the fit 
of the two protomers at the interface of the complex is not optimal. We interpret this 
conformational change as an early event of the detachment of the two proteins.  
 
The correlation of conformational changes between VP24 and KPNA5 were considered next. 
Previous studies have found that the binding of a protein ligand to a protein receptor can result 
in correlated enthalpic backbone motions [11]. Consequently, a model of signal propagation 
built on the analysis of local motions was generated. These were extracted from the molecular 
dynamics simulations by encoding trajectories into sequences of 4-residue fragment states 
with the M32K25 structural alphabet ([12]; see materials and methods for a full description of 
the numerical procedure used) to estimate the propensity of the Ebola virus VP24 R137A 
mutant to remain bound to KPNA5. The local error of the structural alphabet fit for the three 
complexes is shown in figure S3.  
 
The Ebola virus VP24-KPNA5 and Ebola virus VP24(R137A)-KPNA5 complexes were 
encoded with the M32K25 structural alphabet and their collective motions were analysed. We 
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assessed the quality of fragment encoding of the simulations by measuring the local fit root-
mean square deviation of the fragments from the atomistic trajectories (Figure 3). We found 
that the fragment-based encoding produced simplified trajectories with a reasonable special 
accuracy (>1.0 Å) for each of the trajectories analysed. A statistical analysis of the global 
collective motions revealed that the Ebola virus VP24-KPNA5 complex displayed structurally 
correlated motions between distal fragments (Figure 3a). The molecular dynamics simulation 
of the mutant VP24(R137A)-KPNA5 interaction displayed fewer such collective motions 
between the two subunits in the dimer (Figure 3b). In support of this observation, a topological 
analysis of the three simulations revealed that the Ebola virus wild type VP24 complex 
displayed a denser network of inter-subunit correlations than the VP24(R137A) complex 
(Figure 3). Taken together, the physical model presented here would suggest that the wild 
type Ebola virus complex is molecularly optimised for dimerisation, whereas we predict that 
the mutant VP24(R137A) is unlikely to form a stable complex, which is in agreement with the 




Comparison of Ebola virus and Reston virus VP24 interaction with KPNA5 
 
Next, the complex formed between Reston virus VP24 and KPNA5 was investigated with the 
aim of identifying how the interaction between these two proteins may differ from the 
interaction between Ebola virus VP24 and KPNA5. Only an unbound structure of Reston VP24 
was available. Hence, a model of Reston virus VP24 bound to KPNA5 was generated using 
the Ebola virus VP24-KPNA5 complex as a template (see Methods). 
 
mCSM predicted that all of the conserved amino acid changes observed in Reston virus VP24 
would reduce the stability and affinity of the complex, with the exception of M136L, where a 
small increase in affinity was predicted (Table 3). The other changes in stability were similar 
to the predicted change for R137A, which is known to reduce binding [3]. FoldX also predicted 
reduced stability for two (T131S, N132T) of these four point changes, with increased stability 
predicted for M136L and Q139R, although the ''G for M136L is predicted to be very small 
(0.18 kcal/mol). FoldX also predicted a slightly less stable complex with all four amino acid 
changes present (Table 3). Overall these predictions suggest that together the amino changes 
at the Reston virus VP24-KPNA5 interface are likely to reduce the stability and affinity of the 
complex.  
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The interfaces of the Ebola virus VP24- and Reston virus VP24-KPNA5 complexes were 
compared (Table 2) at the beginning and end of the molecular dynamics simulation using 
PISA [9] and POPSCOMP [10]. Both complexes are stabilised by patterns of hydrogen bonds. 
In the X-ray structure of the Ebola virus VP24-KPNA5 complex, nine hydrogen bonds were 
present, while in the model of the Reston virus VP24-KPNA5 complex 11 hydrogen bonds 
were identified to form at the interface. In total three hydrogen bonds were equivalent in the 
two complexes for the energy minimised structures (i.e. at 0ns). Molecular dynamics 
simulations for Ebola or Reston virus VP24 in complex with KPNA5 were then performed for 
600ns. We calculated the number of hydrogen bonds at the interface over the whole trajectory 
(600ns) for both complexes (Figure S4). From the probability distribution of the number of 
hydrogen bonds over the time, we observed that the Ebola virus VP24-KPNA5 complex is 
stabilised by 22 hydrogen bonds on average compared to 18 for the Reston virus VP24-
KPNA5 complex (Figure S4). So during the simulation the complexes have a greater number 
of hydrogen bonds than the starting structures. The four fewer hydrogen bonds at the interface 
of the Reston virus VP24-KPNA5 would suggest that this complex is energetically weaker than 
the Ebola virus VP24-KPNA5 complex. Analysis of the simulations highlighted that in the 
Ebola virus VP24 complex there was a considerable hydrogen bonding network with KPNA5 
(Figure 5B) involving VP24 residues 137-140. However, in the Reston virus VP24-KPNA5 
complex there was only limited hydrogen bonding of VP24 R137 and T138 with KPNA5 D480 
(Figure 5B). In addition, the Ebola virus VP24-KPNA5 complex contains a hydrogen bond 
between VP24 Q139 and KPNA5 E474. In contrast, VP24 R139 points away from KPNA5 and 
towards the solvent in the Reston virus VP24-KPNA5 throughout the simulation (Figure 5B). 
 
Throughout the simulation, the RMSD of the main chain C-Alphas was stable for both 
complexes (Figure S1). The RMSD of the Reston virus VP24-KPNA5 model is greater than of 
the Ebola virus VP24-KPNA5 complex, (Figure S1). This could indicate a difference in the 
interaction between RESTV VP24 and KPNA5 and could also partly reflect that the simulation 
is based on a model rather than a solved structure. 
 
For VP24 some minor differences in fluctuation (RMSF) were observed between the Reston 
virus and Ebola virus proteins. Two of these differences coincided with the interface site at 
residue 113 (Figure 2A). Residue 113 is located in an alpha helix at the interface. For KPNA5 
there are larger differences in RMSF in four regions, three of which coincide with the complex 
interface (Figure 2A). The most pronounced difference is around residues 477-479 (a loop 
region between two alpha helices), where there is very little fluctuation of KPNA5 in the Ebola 
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virus VP24 complex (around 1 Å) but a peak fluctuation of 8 Å in the Reston virus VP24 
complex. The greater fluctuation in KPNA5 suggests that the interaction with Reston virus 
VP24 differs from that with Ebola virus VP24, supporting the evidence that Reston virus VP24 
and human KPNA5 are weaker binding partners than Ebola virus VP24 and human KPNA5. 
 
Analysis of the secondary structure (using DSSP [13]; see methods) during the simulation 
revealed minor changes in the VP24 secondary structure occurring at the interface site 
(supplementary figure S2). The most important changes were found around residue 76 where 
there is a prevalence of turns in Ebola virus VP24 which is a coiled structure in Reston virus 
VP24. Residues 133 and 134 (Figure S2), as well as residue 146, which are proximal to the 
binding interface, lose their bend and beta bridge structures to become unstructured in the 
Reston virus complex. The largest changes in secondary structure were found in KPNA5, 
particularly in two regions between residues 365-375 and 385-395 (Figure S2). The second 
region, which is involved in binding VP24, loses alpha helical structure after 220 ns in the 
Reston virus complex and changes to a turn structure instead. 
 
For the Reston virus VP24-KPNA5 complex, analysis of solvation at the interface identified 
high-density grid points (visited by permanent water molecules) close to the residues E203, 
P204, D205, D124 and R137 (Figure 4C). As in the case of the wild type Ebola virus VP24-
KPNA5 complex, at the interface there are solvation sites where water molecules are trapped 
and contribute to the stabilisation of the complex. In both the wild type Ebola virus and Reston 
virus VP24-KPNA5 complexes high-density grid points were found close to the residues E203, 
P204 and D205.  This means that these residues are important in enhancing the stability of 
both complexes while establishing favourable interactions with water molecules. These 
residues belong to a loop interacting with KPNA5 defining a cavity where the water molecules 
are trapped.  
 
The presence in the Reston VP24-KPNA5 complex of high-density grid points, where water 
molecules are trapped, suggests that part of the interface between Reston virus VP24 and 
KPNA5 may be relatively stable compared to the R137A-mutated Ebola virus VP24-KPNA5 
complex, where only low density grid points were observed, indicating an absence of water 
molecules that would stabilise the complex (Figure 4).  
 
Correlation of conformational changes in the Reston virus VP24-KPNA5 complex was 
compared to the results for the wild type and R137A mutant Ebola virus VP24-KPNA5 
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complexes. No correlated motions were detectable in the simulation of the Reston virus 
complex variant of the VP24-KPNA5 complex (Figure 3c), whereas many were observed for 
the Ebola virus VP24-KPNA5 complex and fewer for the Ebola virus R137A VP24-KPNA5 
complex (see above). Correlation of the conformational changes analysis supported this with 
the Ebola virus VP24-KPNA5 complex having a denser network of inter-subunit correlations 
than did the Reston virus VP24-KPNA5 complex, which reflects the results obtained for the 
R137A mutant Ebola virus VP24-KPNA5 complex (Figure 3). Taken together, these findings 
suggest that Reston virus VP24 forms a less stable complex with KPNA5 than Ebola virus 
VP24, in particular due to the similarity of the results obtained for Reston virus VP24 and 




This study investigated the dynamics of interaction of the Ebolavirus protein VP24 with human 
KPNA5. This interaction occurs during infection to prevent transport of STAT1 to the nucleus 
in order to inhibit interferon signaling [3-5]. Recent findings have identified positions that are 
differentially conserved between human-pathogenic Ebolaviruses and Reston virus, the only 
Ebolavirus that is not pathogenic to humans [8]. In particular three of these positions in the 
interface site between VP24 and human KPNA5 were suggested to affect binding of Reston 
virus VP24 to KPNA5 and to contribute to the lack of human pathogenicity of Reston viruses 
[8]. 
Experimental evidence showed the R137A mutation in Ebola virus VP24 to reduce VP24 
binding to human KPNA5 [3]. Therefore, we compared the Ebola virus VP24-KPNA5 
interaction with the R137A-mutant Ebola virus VP24-KPNA5 interaction to validate our 
system.  In concert with the experimental findings [3], our analysis predicted that the R137A 
mutation reduces VP24-KPNA5 binding. Moreover, the correlations of conformational 
changes and solvation analysis provide novel molecular insights into how this mutation affects 
binding of the two proteins. They show that the mutation reduces the stability of the complex, 
enables the two proteins to move apart from each other, and for water to enter the interface. 
 
The investigation of the interaction of Reston virus VP24 with human KPNA5 added further 
evidence that Reston VP24 is a weaker binding partner to human KPNA5 than Ebola virus 
VP24. This is most strongly suggested by the lack of correlated conformational movements 
between Reston virus VP24 and KPNA5. Some permanent water molecules are (in contrast 
to the R137A-mutated Ebola virus VP24-KPNA5 complex) observed in the interface of the 
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Ebola virus VP24- and Reston Virus VP24-KPNA5 complexes. This indicates some 
differences between the interaction of R137A-mutated Ebola virus VP24 and Reston virus 
VP24 with human KPNA5. 
 
In conclusion, our results suggest that Reston virus VP24 forms a weaker complex with human 
KPNA5 than Ebola virus VP24.  This weaker binding is anticipated to reduce (in comparison 
to Ebola virus VP24) the capacity of Reston virus VP24 to inhibit KPNA5-mediated STAT1 
transport into the nucleus and to anatagonise interferon signalling in human cells. This 
reduced Reston virus VP24-KPNA5 complex stability is likely to contribute to the lack of 
human pathogenicity observed in Reston viruses. Hence, our findings contribute novel 
evidence indicating VP24 to be an important regulator of species-specific Ebolavirus 
pathogenicity, as previously suggested by the analysis of conserved differences between 
Reston viruses and human-pathogenic Ebolaviruses [8]. In addition, our findings provide novel 




Modelling of a RESTV-VP24 KPNA5 complex  
The Ebola and Reston virus VP24 sequences share 81.3% sequence identity and 96% 
similarity. The protein structures were aligned using Chimera [18] and a model for Reston 
VP24 in complex with human KPNA5 built using MODELLER 9.0 [19]. The Reston virus VP24 
crystal structure (PDB 4D9O) and the Ebola virus VP24-KPNA5 complex (PDB 4U2X) were 
used as templates for the Reston virus complex model. 200 models were obtained and the 
one with the lowest DOPE score was selected.    
 
Comparison of interfaces 
PISA [9] and mCSM [9] were used to analyse the structural properties at the complexe 
interfaces, including solvent accessibility and binding affinity. FoldX [10] was used to predict 
the effects of the changes in Energy upon mutation, in terms of effects in  protein stability. 
POPSCOMP [20] was used to determine the contribution of the individual residues to the 
hydrophilicity and hydrophobicity at the interface, according to their solvent accessible surface 
area (SASA), using default parameters. The residues were classified as being part of the core, 
support or rim regions of the interface according to the change in SASA (when the percentage 
of hydrophobicity was greater than 40 and difference in SASA was less than 10 Å2 the residue 
was considered as core, otherwise it was rim).   
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Molecular Dynamics simulations 
Molecular dynamics simulations were performed for the wild type forms of Ebola virus VP24 
and Reston virus VP24 in complex with human KPNA5. Other simulations were performed on 
the Ebola virus VP24-KPNA5 complex with mutations introduced into VP24 where the effect 
on KPNA5 binding had been experimentally determined [3]. The mutations considered were: 
1)R137A, 2)Q139A, 3)F134A,M136A and  4) R137A-Q139A.  
 
Molecular dynamics simulations were performed using Gromacs 5.0.5 [21].  The initial 
structures were solvated with a cubic box of SPC water molecules, setting the minimal 
distance between the protein and the box boundaries to 12 Å. Ionisable residues were 
modeled in their standard protonation state at pH 7. The systems were then neutralised adding 
the appropriate number of counterions. The GROMOS 53a6 parameter set [22] was used. 
Periodic boundary conditions were imposed. All the bonds were frozen and a 2-fs time step 
was used. The Berendsen algorithm [23] was employed for temperature and pressure 
regulation, with coupling constants of 0.2 and 1 ps, respectively. The electrostatic interactions 
were calculated with the particle mesh Ewald method [24] with a 14 Å cutoff for the direct 
space sums, a 1.2 Å FFT grid spacing, and a 4-order interpolation polynomial for the reciprocal 
space sums. For Van der Waals interactions, a 14 Å cutoff was used. The neighbour list for 
non-covalent interactions were updated every 5 steps. The systems were first minimised with 
1000 steps of steepest descent. Harmonic positional restraints with a force constant of 4.8 
NFDOPROcí ZHUH LPSRVHG RQWR WKH SURWHLQ KHDY\ DWRPV DQG JUDGXDOO\ UHGXFHG WR 
NFDOPROcíLQSVZKLOHWKHWHPSHUDWXUHZDVLQFUHDVHGIURPWR.DWFRQVWDQW
volume. The system was then simulated at constant temperature (300 K) and pressure (1 bar) 
for 100 ps. After the removal of harmonic restraints, 2 ns of equilibration were run in NPT 
conditions. NPT production simulations were then run for 40 ns for each system. System 
coordinates were saved every 1 ps. 
 
We selected the force field GROMOS 53a6 because is the latest version of the  widely used 
force field [25] from the GROMOS family stemming from the most widely used GROMOS 
43A1. These parameter sets are often selected in performance studies where force fields are 
assessed and compared [26-29], and where it is shown that it is still one of the best united-
atom force fields available, providing in some cases even better results than some all-atom 
force fields. Additionally, it is known since a while that the 43A1 parameter set provides better 
alpha/beta relative stabilities than GROMOS parameter sets developed later [30]. 
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600 ns MD trajectories were obtained for the Ebola virus VP24-KPNA5 complex and the model 
of the Reston virus VP24-KPNA5 complex. In our analysis, we omitted the first 280ns of the 
simulation, as this was the approximate time required for each of the systems to reach 
conformational equilibrium. 200 ns trajectories were obtained for R137A and F134A, M136A 
and 100 ns for all other simulations. 
 
Molecular Dynamics Analysis 
Trajectories were analysed using the GROMACS analysis tools, VMD tools and the Bio3D 
package for R [31,32]. For the analysis, standard Periodic Boundary Conditions were removed 
and Minimum Image Convention (MIC) were applied to all the trajectories. Rotational and 
translational movements were then deleted in order to perform the Principal Component 
Analysis. Secondary structure plots for trajectories were obtained using the DSSP [33] tool in 
gromacs. Root mean square deviation (RMSD) and fluctuation (RMSF) from the initial starting 
complex were obtained using Bio3D, as well as the PCA analysis and correlation plots.  
 
Analysis of correlation of conformational changes  
We used a fragment-based approach to simplify the local structure of each of the three 
molecular dynamics simulations. The structural alphabet M32K25 was used to encode 
fragments of four consecutive CĮ atoms, so as to describe backbone conformations of the 
protein in a simplified manner [12].  Mutual information between two sets of fragments (i,j) was 
used to calculate the correlation in conformational changes using a numerical procedure 
outlined in [12]: 
ܫ௡ ൌ ܫ൫ܥ௜Ǣ ܥ௝൯ െ ߳൫ܥ௜Ǣ ܥ௝൯ܪ൫ܥ௜ ǡ ܥ௝൯  
where Ci and Cj are columns in the structural string alignment, I(Ci;Cj) is the mutual 
information, H(Ci;Cj) is the joint entropy and İ&i;Cj) is the error. 
 
Considering the fragment at positions Ci and Cj as a discrete distribution of fragments X and 
Y, we calculated the joint entropy H(X,Y) as a pair of discrete random variables (X,Y) with a 
joint distribution p(x,y) defined as ܪሺܺǢ ܻሻ ൌ െ෍෍݌ሺݔǡ ݕሻ݈݋݃݌ሺݔǡ ݕሻ௬ఢ௒௫ఌ௑  
where p(x) and p(y) are the associated marginal probabilities. 
 
  13 
 
Analysis of solvation in the interaction surface 
To perform the water density analysis, structures were simulated, as previously described, for 
 QV E\ 0' ZLWK EDFNERQH UHVWUDLQWV  NFDOā PROíā cí  WR DYRLG DQ\ VLJQLILFDQW
conformational changes of the protein during the simulation [31]. Water density maps were 
calculated at discrete points r defined by a 0.5-Å spaced rectangular grid around the solute. 
Each structure of the last 10 ns of the trajectory was superimposed to a reference to remove 
the overall roto-translational motion of the protein. The number density of the water oxygen 
atoms was then averaged at each grid point over the MD snapshots extracted every 0.1 ps 
and normalised by the bulk density evaluated in the 6-8 Å shell around the solute. The 
hydration sites were then identified as local maxima of the density map with g(r) > 1 and used 
to define the hydration score Shyd as previously described [34]. Water density maps were 
calculated for representative conformations of the Ebola virus VP24-KPNA5 complex as 
extracted from the trajectory and compared to the solvent distribution for the representative 
conformations of Ebola virus R137A VP24-KPNA5 and Reston virus VP24-KPNA5 complex 
trajectories.  
 
A good water model to use as a solvent in biomolecular simulations should be computationally 
efficient and at the same time reproduce accurately enough the properties of bulk water. Not 
to be underestimated, this model should be compatible with the force field used for the solute 
interactions.  It is well known that simple effective pair potentials such as SPC, TIP3P and 
TIP4P are, in different measure, not able to accurately describe the entire range of water 
properties, nevertheless, they have all proven to successfully model water as a solvent in 
biomolecular simulations.  
The general weakness demonstrated by these models is in the overestimation of the diffusion 
coefficient and the inaccurate description of the dielectric properties. On the other hand they 
are effective in the calculation of solute solvent energies and practical to use. In the past we 
have developed solvent density maps based on the SPC model [34,35]. We were particularly 
interested in the water-protein interactions due to the localization of water at the surface of the 
protein, therefore we used the same model in this application as a matter of consistency with 
the force field and our previous calculations. 
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Figure Legends 
Figure 1. Ebola virus VP24 complex with KPNA5. VP24 is coloured grey and KPNA5 is blue. 
Residues differentially conserved between Ebola and Reston viruses are shown in red 
(present in interface), orange (not in the interface site), they are  and labelled with the Ebola 
virus amino acid, residue number followed by the Reston virus amino acid. 
 
Figure 2: Root Mean Square Fluctuation (RMSF) for simulation of mutated Ebola virus VP24 
with human Karyopherin RMSF for the mutants over the wild type complex. EBOV VP24 (on 
the left side of each graph) and KPNA5 (on the right) are shown. In black line the wild type 
complex RMSF is shown; in A), the red line shows R137A mutant, in B) the blue line shows 
the Q139A, in C) the magenta shows F134A-M136A mutant, in D) in cyan R137A-Q139A 
mutant are shown. In light blue the residues that are occurring at the interface are mapped 
under each curve.  
 
 
 Figure 3: Correlation of conformational Changes in the VP24-KPNA5 molecular dynamics 
simulations. All-atom molecular dynamic simulations of a) Ebola VP24, b) Ebola VP24 
R137A (shown in red) and d) Reston VP24 with human KPNA5 complex were encoded with 
the M32K25 structural alphabet and analysed for global correlated motions between distal 
backbone fragments. The top 10% most significant correlated motions were selected and 
are represented by yellow strings. 
 
Figure 4: Solvation analysis of the VP24-KPNA5 complexes. In parts A, B and C the 
spheres represent the most visited grid points coloured from red to blue, with red being a low 
density grid point (short temporal permanence [ps] of water molecules) and blue a high density 
grid points (long temporal permanence [ns] of waters). A) High density grid points were found 
close to the residues N185, H186, E203, P204 and D205 in the Ebola virus VP24 with human 
KPNA5 complex. B) The Ebola virus mutant R137A VP24-KPNA5 complex at the interface is 
characterized only by low density grids points meaning that waters are not trapped and 
consequently do not contribute to the stabilization of the complex. The mutation induces a 
long-range destabilization of the complex determining the creation of a cleft at the interface 
where waters can freely enter and exit. C) For the Reston virus VP24 complex, the analysis 
of solvation at the interface identified high-density grid points close to the residues E203, 
P204, D205, D124 and R137.  
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Figure 5. Hydrogen bonding in the Ebola and Reston virus VP24 complexes with KPNA5. 
VP24 hydrogen bonding with KPNA5 in the region of residues R137-R140. Top two panels 
are for VP24 with the initial minimised structure (left) and the structure at the end of the 
simulation (right). Bottom panels show the equivalent for Reston VP24. In all images VP24 is 
coloured grey.  
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Table 1 Predicted effect on Ebola VP24-KPNA5 complex stability by mutations in Ebola VP24. 
Prediction from mCSM (stability and affinity) and FoldX (stability) were calculated for the 
mutated complexes.  
 
Mutation mCSM stability 
( G - kcal/mol) 
mCSM PP affinity 
( G - kcal/mol) 
FoldX stability 
( G - kcal/mol) 
R137A -0.80 -1.07 -0.68 
Q139A 
 
-0.39 -0.24 -0.33 
F134A,M136A NA NA -7.3 
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Table 2: PISA and POSPCOMP Interface Analysis at 0 and 600 ns MD snapshots. 
 
 Ebola VP24 ±KPNA5 
complex 
 
Reston VP24 ±KPNA5 
complex 
 
PISA results  
PISA results at 0 ns  
Interface Area ( Å2 ) 1099.7 1055.1 
Solvation Free Energy ('iG, 
Kcal/M) 
-8.5 -8.6 
Hydrogen bonds 9 11 
PISA results at 600 ns  
Interface Area ( Å2 ) 1119.2 1076 
Solvatation Free Energy 
('iG , Kcal/M) 
-10 -9.1 
Hydrogen bonds 7 11 
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Table 3: Predicted effect on Ebola virus VP24-KPNA5 complex stability by mutation of 
residues that are differentially conserved in Reston in Ebola VP24. Prediction from mCSM and 
FoldX are shown changes for the in the EBOV VP24 ±KPNA5 complex.  
 
 
Mutation mCSM stability 
( G - Kcal/mol) 
mCSM PP affinity 
( G - Kcal/mol) 
FoldX stability 
( G - Kcal/mol) 
T131S 
 
-1.29  -0.32  -0.42  
N132T 
 
-0.62  -2.65  -1.22  
M136L 
 
-0.81  0.17  0.18  
Q139R 
 
-1.06  -0.99  1.59  
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Figure 5 
 
 
 
 
 
